Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

Practitioners commonly use amikacin in patients with cystic fibrosis. Establishment of the pharmacokinetics of amikacin in adults with cystic fibrosis may increase the efficacy and safety of therapy. This study was aimed to establish the population pharmacokinetics of amikacin in adults with cystic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Illamola, Sílvia M., Huynh, Hoa Q., Liu, Xiaoxi, Bhakta, Zubin N., Sherwin, Catherine M., Liou, Theodore G., Carveth, Holly, Young, David C.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2018
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6153835/
https://ncbi.nlm.nih.gov/pubmed/30061295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00877-18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares